Loading fund overlap…
18 of 162 unique stocks in common · Jaccard: 11.1%
A weighted portfolio overlap of 11.63% indicates a low overlap (mostly different holdings). This means that out of every ₹100 you invest across these two schemes, approximately ₹11.63 is allocated to the exact same companies at the same relative proportions. The schemes share 18 common holdings.
The largest overlapping asset in their portfolios is Reliance Industries, which commands a weight of 3.42% in ICICI Prudential Multi-Asset Fund and 3.32% in Kotak Manufacture In India Fund. Holding both schemes increases your concentration in Reliance Industries rather than expanding your diversification.
If the overlap is above 30%, it is typically because both schemes benchmark to the same index (e.g. Nifty 50 or Nifty LargeMidcap 250) or overlap in their top large-cap picks. To improve your portfolio's diversification, consider allocating one of these tranches to a category with lower structural correlation (such as a mid-cap, small-cap, or international equity fund).
| Stock | in ICICI | in Kotak |
|---|---|---|
| Reliance IndustriesPetroleum Products | 3.42% | 3.32% |
| Maruti Suzuki IndiaAutomobiles | 1.70% | 3.13% |
| Sun Pharmaceutical IndustriesPharmaceuticals & Biotechnology | 1.15% | 4.72% |
| Page IndustriesTextiles & Apparels | 0.87% | 1.57% |
| Tata MotorsAgricultural, Commercial & Construction Vehicles | 0.82% | 0.89% |
| Tata SteelFerrous Metals | 0.68% | 3.73% |
| BioconPharmaceuticals & Biotechnology | 0.47% | 1.44% |
| Mahindra & MahindraAutomobiles | 0.45% | 4.32% |
| Eicher MotorsAutomobiles | 0.34% | 1.99% |
| Hindalco IndustriesNon - Ferrous Metals | 0.33% | 2.64% |
| TVS Motor CompanyAutomobiles | 0.33% | 3.65% |
| Britannia IndustriesFood Products | 0.30% | 1.65% |
| Bharat ElectronicsAerospace & Defense | 0.30% | 2.66% |
| Hero MotoCorpAutomobiles | 0.12% | 2.92% |
| Jindal SteelFerrous Metals | 0.12% | 0.93% |
| Hindustan Petroleum CorporationPetroleum Products | 0.12% | 1.85% |
| Bharat Petroleum CorporationPetroleum Products | 0.11% | 1.52% |
| Divi's LaboratoriesPharmaceuticals & Biotechnology | 0.08% | 2.73% |
Weighted overlap = Σ min(weight in fund A, weight in fund B) across shared stocks, from each fund's latest public monthly portfolio (as on Jul 2026). Equity holdings only, ISIN-verified. Not investment advice.